GB Sciences (GBLX) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free GBLX Stock Alerts $0.0063 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGB News posts £42m loss but grows online audiencebbc.com - March 12 at 7:38 PMGb Sciences’ Novel Parkinson’s Disease Medication is Featured on Worldwide Business with kathy ireland(R)finance.yahoo.com - December 14 at 10:26 AMTeam GB News: Medals and Schedule at Winter Olympicsdailymail.co.uk - November 2 at 8:15 AMDan Wootton's replacement on GB News revealed as he's suspended over Laurence Fox rantmirror.co.uk - October 8 at 9:57 AMGB News boss explains why Dan Wootton is still on air amid allegations against presentermirror.co.uk - October 6 at 2:04 AMGB News suspends third presenter for supporting Dan Wootton in Laurence Fox rowmirror.co.uk - October 3 at 10:18 AMGB News - Updates on the British television news channeldailymail.co.uk - October 2 at 12:36 AMGb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of Lethbridgefinance.yahoo.com - July 11 at 8:10 AMINSIGHT-Lab crunch: British science has nowhere to goreuters.com - June 20 at 11:08 AMGBLX - GB Sciences, Inc.finance.yahoo.com - May 27 at 12:19 PMGB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in Chinafinance.yahoo.com - March 20 at 9:41 AMSuccessful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery Platformfinance.yahoo.com - March 7 at 10:46 AMGB Sciences Stock (OTC:GBLX), Quotes and News Summarybenzinga.com - February 18 at 1:49 AMGb Sciences Identifies Novel Cannabis-Inspired Mixtures That Could Treat Viral Infectionsbenzinga.com - December 26 at 8:18 PMGb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulationsfinance.yahoo.com - December 12 at 7:51 AMCannabis Terpenes Reduce Inflammation, Says Gb Sciences Studymsn.com - November 1 at 6:44 PMGb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredientsfinance.yahoo.com - November 1 at 8:42 AMTODAY: Gb Sciences' President Demonstrates Benefits of AI-Enabled Drug Discovery Engine for Novel Plant-Inspired Pharmaceuticals at 10th Annual Drug Discovery Strategic Summitfinance.yahoo.com - October 27 at 11:31 AMGb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Studyfinance.yahoo.com - October 24 at 8:13 AMTODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 Conferencefinance.yahoo.com - October 13 at 9:55 AMNew Study Shows Promising Results In Treatment Of Parkinson's Disease With Cannabinoidsmsn.com - October 10 at 9:46 AMGb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's Diseasefinance.yahoo.com - October 10 at 9:46 AMTODAY: Gb Sciences Describes Drug Development Progress in Pharma's Almanac Journal Articlefinance.yahoo.com - September 6 at 11:29 AMGB Sciences, Inc. (GBLX)ca.finance.yahoo.com - August 9 at 12:03 AMGb Sciences Leads Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform-PhAROS(TM)stockhouse.com - July 20 at 12:07 AMGb Sciences is Leading Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform—PhAROS™finance.yahoo.com - July 19 at 2:05 PMGb Sciences Leads Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform—PhAROS™finance.yahoo.com - July 18 at 11:59 AMTODAY: Gb Sciences' President and Chief Science Officer Presents Keynote Address on Cannabinoid-Containing Formulations for Parkinson's Disease at 2022 NeuroForum Summitfinance.yahoo.com - May 23 at 5:59 PMTODAY: Gb Sciences Showcases Its PhAROS(TM) Drug Discovery Platform at the 2nd ALCOR Drug Discovery Platform Summitstockhouse.com - May 12 at 1:53 PMTODAY: Gb Sciences Showcases Its PhAROS™ Drug Discovery Platform at the 2nd ALCOR Drug Discovery Platform Summitfinance.yahoo.com - May 12 at 1:53 PMTODAY: Gb Sciences' Novel Plant-Inspired Pain Medications Featured at SMi's 22nd Annual Pain Therapeutics Conferencefinance.yahoo.com - May 5 at 9:46 AMFHI Clinical to Write Clinical Trial Protocol for Development of Gb Sciences' COVID-19-Related, Anti-Inflammatory Therapiesfinance.yahoo.com - May 2 at 1:36 PMGb Sciences To Begin Dosage Study For Cannabinoid-Containing Drug For Treatment Of Parkinson's Diseasemsn.com - April 17 at 12:59 AMGb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of Lethbridgefinance.yahoo.com - April 12 at 10:42 AMGb Sciences' Nanoparticle Encapsulation Technology Improves the Efficacy of Terpenes for Use in Our Chronic Pain Formulations as Demonstrated in New Research Articlefinance.yahoo.com - March 29 at 6:49 PMUPDATE: Gb Sciences Issues Shareholder Letterfinance.yahoo.com - March 16 at 7:15 PMGb Sciences Issues Summary Shareholder Letterfinance.yahoo.com - March 15 at 8:10 AMGb Sciences gets US patent for cannabinoid-containing mixture to treat heart diseaseseekingalpha.com - March 1 at 4:57 PMGb Sciences Granted U.S. Patent for Cannabinoid-Containing Treatment for Advanced Heart Disease, TRPV1-Receptor-Associated Hearing Loss and Urinary Cystitisfinance.yahoo.com - March 1 at 4:57 PMNot So Fast With The Cannabis-COVID Treatment: Gb Sciences And Michigan State U Researchers Clarifymsn.com - February 1 at 12:30 PMGb Sciences and Michigan State University Researchers Have Identified the Complicated Truth Behind the Opportunity for an Effective Cannabinoid-Based Coronavirus Treatmentfinance.yahoo.com - February 1 at 12:30 PMGb Sciences Leaves Cannabis Cultivation With $8M Sale Of Las Vegas Facility, Enters BioPharma Industrymsn.com - January 11 at 2:40 PMGb Sciences Completes $8 Million Sale of Las Vegas Cannabis Facilityfinance.yahoo.com - January 11 at 9:40 AMGb Sciences Targets COVID-19 Treatment as Omicron Variant Arrivesfinance.yahoo.com - December 6 at 7:59 AMGb Sciences Starts Preclinical Study for Plant-Based Formulas to Treat Depression and Anxietyfinance.yahoo.com - November 1 at 11:09 AMGb Sciences Achieves Positive Proof-of-Concept Results for Their Cytokine Release Syndrome Therapies Designed to Suppress COVID-Related Hyperinflammationfinance.yahoo.com - September 14 at 11:51 AMGb Sciences Presenting COVID-Related Cytokine Release Syndrome Results at H.C. Wainwright's 23rd Annual Global Investment Conferencefinance.yahoo.com - September 9 at 6:25 PMGb Sciences to Present at the SNN Network Summer Virtual Event on Wednesday, August 18th, 2021finance.yahoo.com - August 10 at 1:44 PMGB Sciences Is Developing Plant-Inspired Mixtures for Anxiety, Depression, and Pain From PhAROS, GB Sciences' Proprietary AI-Accelerated Drug Discovery Platformfinance.yahoo.com - July 27 at 1:43 PM Get GB Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GBLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. GBLX Media Mentions By Week GBLX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GBLX News Sentiment▼1.000.33▲Average Medical News Sentiment GBLX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GBLX Articles This Week▼10▲GBLX Articles Average Week Get GB Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GBLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News ALK-Abelló A/S News Alpha Tau Medical News Arno Therapeutics News Artelo Biosciences News Ascletis Pharma News Awakn Life Sciences News AXIM Biotechnologies News BerGenBio ASA News BriaCell Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:GBLX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GB Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
